Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis

Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Nov 3, 1999

Keywords

ClinConnect Summary

Pulmonary fibrosis that develops within a subpopulation of patients with rheumatoid arthritis is a disorder of unknown etiology. Although previous reports suggest that some individuals with rheumatoid arthritis have a genetic predisposition to the development of fibrotic lung disease, genetic factors have not been clearly identified. It is the intent of this clinical protocol to identify genetic polymorphisms in individuals with pulmonary fibrosis and rheumatoid arthritis.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• Individuals 21 years of age or older with any of the following:
• • RA (based on 1987 American College of Rheumatology Revised Criteria for the Classification of RA) with PF (biopsy-proven), or
• • RA-only, or
• • Biopsy-proven idiopathic PF-only, or
• • Healthy research volunteers.
• EXCLUSION CRITERIA:
• Individuals with any of the following:
• • Inhalational exposure to fibrogenic fibers or dusts (e.g., asbestos, silica, coal, beryllium).
• • Chronic pulmonary disorders other than pulmonary fibrosis.
• • Other collagen vascular disorders (e.g., systemic lupus erythematosus, scleroderma, polymyositis, mixed connective tissue disease).
• • Non-rheumatoid arthritis.
• • Viral infections associated with PF (e.g., hepatitis B, hepatitis C, human immunodeficiency virus).
• • Pregnancy.